Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyslipidaemia and obesity

J P Després1

  • 1Lipid Research Center, CHUL Research Center, Ste-Foy, Quebec, Canada.

Bailliere'S Clinical Endocrinology and Metabolism
|July 1, 1994
PubMed
Summary

Visceral obesity, characterized by abdominal fat, is linked to metabolic issues like insulin resistance and dyslipidemia. Reducing visceral fat and improving insulin sensitivity are key treatment goals for preventing heart disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian networks and imaging-derived phenotypes highlight the role of fat deposition in COVID-19 hospitalisation risk.

Frontiers in bioinformatics·2023
Same author

Evaluation of Adiposity and Cognitive Function in Adults.

JAMA network open·2022
Same author

Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men.

International journal of obesity (2005)·2015
Same author

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.

International journal of obesity (2005)·2014
Same author

Weight loss and regain in obese individuals: a link with adipose tissue metabolism indices?

Journal of physiology and biochemistry·2013
Same author

Interactions between dietary fat intake and FASN genetic variation influence LDL peak particle diameter.

Journal of nutrigenetics and nutrigenomics·2011

Area of Science:

  • Metabolic Syndrome
  • Obesity Research
  • Cardiovascular Disease Risk Factors

Background:

  • Obesity is often linked to dyslipidemia, a state of abnormal blood lipid levels.
  • Regional fat distribution, particularly visceral adipose tissue, is crucial for assessing obesity-related health risks.
  • Imaging techniques like computed tomography confirm visceral fat's role in metabolic complications.

Purpose of the Study:

  • To highlight the critical role of visceral adipose tissue in metabolic complications associated with abdominal obesity.
  • To emphasize that visceral obesity exacerbates genetic susceptibility to dyslipidemia and heart disease.
  • To propose treatment strategies targeting visceral fat reduction and insulin sensitivity improvement.

Main Methods:

  • Review of metabolic and epidemiological studies from the 1980s.
  • Utilization of data from imaging techniques such as computed tomography.
  • Analysis of genetic factors influencing plasma lipoprotein-lipid levels.

Main Results:

  • Visceral adipose tissue is a critical correlate of metabolic complications including insulin resistance, hyperinsulinaemia, and abnormal lipid profiles (hypertriglyceridaemia, hypoalphalipoproteinaemia, dense LDL).
  • Visceral obesity acts as a permissive factor, amplifying individual susceptibility to dyslipidemia and premature coronary heart disease, rather than being a primary cause.
  • Insulin resistance and visceral adipose tissue levels are key factors in the dyslipidemia of abdominal obesity.

Conclusions:

  • Treatment for abdominal obesity-related dyslipidemia should focus on reducing visceral fat and enhancing insulin sensitivity.
  • Prospective studies are needed to confirm the benefits of these interventions on coronary heart disease incidence.

Related Experiment Videos